Researchers have been excited about Retatrutide , a groundbreaking dual agonist showing promising data in early trials for weight reduction . It functions by impacting both hormones : GLP-1 and GIP, which , when engaged , support influence hunger and enhance metabolism . Early observations indicate noteworthy size loss and possible advantages for i